Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura

Bone Marrow Transplantation

Volumn 41, Issue 12, 2008, Pages 1063-1065

  Carella, A M ^a   D'Arena, G ^a   Greco, M M ^a   Nobile, M ^a   Cascavilla, N ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BILIRUBIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFIBROTIDE; FLUDARABINE; HAPTOGLOBIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; MELPHALAN; METHYLPREDNISOLONE; PROCYCLID; RITUXIMAB; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; ARTICLE; BRONCHOPNEUMONIA; CASE REPORT; DEATH; DRUG MEGADOSE; FEMALE; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FAILURE; MAINTENANCE THERAPY; PLASMAPHERESIS; PRIORITY JOURNAL; RETICULOCYTOSIS; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 47849109877     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.25     Document Type: Article

References (8)

1. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting? Bone Marrow Transplant 2007; 40: 709-719.
2. Ruutu T, Hermans J, Niederwieser D, Greatwhol A, Kiehl M, Volin L et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: A survey of the European group for blood and marrow transplantation (EBMT). Br J Haematol 2002; 118: 112-119.
3. George JN. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-1934.
4. An W-Y, Ma ES, Lee T-L, Ha S-Y, Fung AT, Lie AKW et al. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol 2007; 137: 475-478.
5. Gallerani E, Lerch E, Romagnani E, Stathis A, Giardelli G, Zwhalen H et al. Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab. Eur J Haematol 2006; 77 527-529.
6. Yassa SK, Blessios G, Marinides G, Venuto RC. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening haemolytic-uremic syndrome. Clin Transplant 2005; 19: 423-426.
7. Ostronoff N, Ostronoff F, Calixto R, Florencio R, Florencio M, Domingues MC et al. Life-threatening haemolytic-uremic syndrome treated with rituximab in an allogencic bone marrow transplantation recipient. Bone Marrow Transplant 2007; 39: 649-651.
8. Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic micro-angiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 571-575.